Fluid Pharma is pleased to announce that it has secured $1.9m of funding from Unitaid as part of new initiative to deliver enhanced malaria treatment to children across Africa. The grant, which is led by Dr Fang Liu at Fluid Pharma, will run over 24 months and will utilise Fluid Pharma’s proprietary MicroCoat™ technology for manufacture of taste masked Fixed-Dose Combination formulations for paediatric use. We also thank the support of the following partners who will help Fluid Pharma to deliver this project:

• UCL School of Pharmacy (Professor Catherine Tuleu)
• University of Greifswald (Professor Sandra Klein)
• University of Hertfordshire (Dr Dan Baker)
• Glatt Pharmaceutical Services (Sascha Dahlmann, Philippe Tschopp and Annette Grave)
• Catalent (Dr Dan Caplin)
• NGT Biopharma Consultants (Dr Daniel Schaufelberger)

To view the press-release on this award, please visit:

https://unitaid.org/news-blog/paediatric-medicines-innovations-awarded-unitaidexplore-funding/. 

Our special thanks go out to the Unitaid team and grant review panel for selecting Fluid Pharma to lead this initiative.